ライフサイエンスコーパス: hookworm infection

1 immunity and restricts lung injury following hookworm infection.

2 viduals with LTB with or without concomitant hookworm infection.

3 but not IL-4-driven Type 2 responses during hookworm infection.

4 SP-2-specific IgE likely induced by previous hookworm infection.

5 ency anemia that is the clinical hallmark of hookworm infection.

6 on the risk of an individual harboring heavy hookworm infection.

7 anti-ASP-2 IgE levels and the risk of heavy hookworm infection.

8 important new tool for the control of human hookworm infection.

9 -1 is a possible drug and vaccine target for hookworm infection.

10 are efficacious vaccines in animal models of hookworm infection.

11 of Australia who were suffering from endemic hookworm infection.

12 weight loss and anemia caused by a secondary hookworm infection.

13 species for examining host immunity to human hookworm infections.

14 s expressing IFNgamma were reduced following hookworm infection (23.9%-11.5%; P = .04), with correspo

15 However, in infants of mothers with hookworm infection, albendazole treatment reduced interl

16 e association between Plasmodium-species and hookworm infection among preschool-aged children (odds r

17 Hookworm infection and gluten exposure were associated w

18 Hookworm infections and tuberculosis (TB) are coendemic

19 Hookworm infection appeared to modify the relationship b

20 Mortality was lower in subjects with hookworm infection at enrollment.

21 s observed among children without detectable hookworm infection, but no association was observed amon

22 risk of wheeze was independently reduced by hookworm infection by an odds ratio of 0.48 (95% CI 0.24

23 Other molecular mechanisms of hookworm infection cause a systematic suppression of the

24 In school-age children, hookworm infection does not produce inflammation or incr

25 Thus, coincident hookworm infection exerts a profound inhibitory effect o

26 g human immunity to both schistosomiasis and hookworm infection has been associated with IgE response

27 These results suggest that hookworm infections have an immunomodulatory effect by i

28 of an effective recombinant vaccine against hookworm infection in humans.

29 t loss and anemia) of Ancylostoma ceylanicum hookworm infection in Syrian golden hamsters of the outb

30 Predisposition to human hookworm infection in this area results from a combinati

31 pathogenesis by allowing the study of adult hookworm infections in a species with well-characterized

32 Hookworm infection, in contrast, was associated with exp

33 ficant role for host genetics in determining hookworm infection intensity has also been shown, but th

34 In multivariate analyses, hookworm infection intensity was the strongest explanato

35 Hookworm infection is a major cause of anemia and malnut

36 Human hookworm infection is a major cause of anemia and malnut

37 Hookworm infection is a major cause of iron deficiency a

38 Hookworm infection is associated with growth delay and i

39 Together, these data demonstrate that hookworm infection is associated with impaired function

40 escence-activated cell sorting revealed that hookworm infection is associated with reduced percentage

41 Predisposition to heavy or light human hookworm infection is consistently reported in treatment

42 Our data show that, although hookworm infection leads to a minor increase in microbia

43 nd 73% of severe anemia were attributable to hookworm infection; < 10% of anemia was attributable to

44 Treatment of hookworm infection neither affected inflammation biomark

45 hamsters (i.e., those with neither previous hookworm infections nor treatment) were also vaccinated.

46 Experimental hookworm infection of the trial subjects resulted in mai

47 sed to determine the impact of A. ceylanicum hookworm infection on host cytokine responses and lympho

48 To determine the role of coincident hookworm infection on responses at steady-state and on M

49 so we examined the influence of experimental hookworm infection on the predicted outcomes of escalati

50 he effect of concurrent (active) and treated hookworm infections on the immunogenicity of vaccination

51 ng shoes was associated with reduced odds of hookworm infection (OR 0.29, 95% CI 0.18-0.47) and infec

52 es (OR 0.62, 95% CI 0.44-0.88), but not with hookworm infection (OR 0.80, 95% CI 0.61-1.06).

53 5% confidence interval [CI], 1.03-2.14), and hookworm infection (OR, 1.77; 95% CI, 1.22-2.55) were th

54 lopment of NTD vaccines, including those for hookworm infection, schistosomiasis, leishmaniasis, and

55 demonstrate that the presence of coincident hookworm infection significantly diminished both spontan

56 As part of on-going efforts to control hookworm infection, The Human Hookworm Vaccine Initiativ

57 ring chronic helminth infection; at least in hookworm infection, this suppression may protect against

58 iron restriction mediates susceptibility to hookworm infection using the hamster model of Ancylostom

59 In addition, hookworm infection was associated with a significantly r

60 1.34; 95% CI, 1.05-1.71; 20 studies), while hookworm infection was associated with a significantly s

61 Additionally, coincident hookworm infection was associated with increased adaptiv

62 Predisposition to heavy or light hookworm infection was observed, with a phenotypic corre

63 h P. falciparum infection, but the effect of hookworm infection was seen only in the absence of M. pe

64 Hookworm infection was undetectable after 1 year.

65 CRs against hookworm infection were 57% (moxidectin) and 56% (iverme